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ABSTRACT 
 
 Eurygaster integriceps Puton, more commonly known as Sunn pest, is 
regarded as one the most harmful pests of wheat, specifically durum wheat and 
bread wheat (Javahery, 1995). They primarily infest the wheat fields of Central 
and Western Asia, as well as areas of Northern Africa and Eastern Europe. The 
pest parasitizes the wheat grains by injecting a prolyl-endylprotease (spPEP), a 
proteolytic enzyme, which degrades the gluten proteins, enabling it to eat 
(Darkoh et al., 2010). Even minimal damage of wheat grains by the Sunn pest (2-
3%) can reduce the grain crop to being unusable in baking (Hariri et al., 2000). 
The impact of the pest in these regions has been extremely detrimental to their 
respective local economies, and more importantly, their overall livelihood. Within 
these locations, wheat is the main source of human food, with over 100 million 
tons of wheat based products harvested annually (Javahery, 1995).   
 To tackle this dilemma, potential inhibitory peptides to the spPEP are being 
considered. Previously, it has been shown that peptides isolated from 
Lactobacillus hydrolysates of caseins in bovine milk can inhibit mammalian PEP 
in colon cells (Juillerat-Jeanneret et al., 2011). While these peptides are potential 
inhibitors of the spPEP, recombinant versions must be created and tested to 
ensure that they are specific to spPEP.  
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To conclude whether these proposed inhibitory proteins can be used as a bio-
pesticide or even function to negate the detrimental effects of spPEP and recover 
compromised wheat grains for human consumption, the inhibitors must have a 
specificity for spPEP while not having an impact on the mammalian PEP 
homologue. The focus of this proposed research project was to clone the human 
prolyl-endylpeptidase (hPEP) into an expression vector and then transform hPEP 
construct into the same expression system as that used for the spPEP. Following 
a confirmation of the desired enzyme activity, it was then expressed in a large 
culture volume and partially purified. As a result of this project, future studies to 
compare the effects of potential inhibitors on hPEP and spPEP will be possible. 
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INTRODUCTION 
Eurygaster integriceps Puton 
 Eurygaster integriceps Puton, more commonly known as Sunn pest, is a 
heteroperous insect, belonging to the order Hemiptera within the family 
Scutelleridae that resides in Northern Africa, Europe, as well as Western and 
Central Asia. It primarily consumes the wheat grains of Triticum aestivum and 
Triticum turgidum (Javahery, 1995). This is problematic, as these grains are vital 
for bread production in the region. With as little as 2% of grain contamination by 
Sunn pest, entire yields of crops can be rendered useless (Hariri et al., 2000). 
 When feeding, the Sunn pest injects the grain with an enzyme known as 
Prolyl Endoprotease (spPEP) which degrades the gluten proteins, rendering the 
grain no longer functional for bread production. While the damage is only 
localized to the grain that the Sunn pest is eating, the damage is significantly 
propagated when the grain is milled (Darkoh et al., 2010 and Vaccino et al., 
2006). 
PEP (Prolyl Endylpeptidase) 
 Prolyl endylpeptidase, otherwise referred to as prolyl oligopeptidase 
(POP), is an enzyme that has been found to be universal to all organisms 
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(Szeltner and Polgar, 2008, and Rawlings and Barrett, 1994). PEPs belong to the 
S9 family of enzymes; they are ubiquitous serine proteases, by activity which is 
mediated by an α/β hydrolase domain (Rawlings and Barrett, 1994). This domain 
contains a conserved catalytic triad, Ser-Asp-His, that is believed to be involved 
in the entry and cleaving of the substrate (Polgar, 2000). PEP isoforms have 
been identified in bacteria, fungi, insects, and animals.  Depending on the 
organism, PEPs can vary in function. 
   For reference, the Km and Kcat in the literature for porcine PEP are 5.9 ± 
0.5 µM and 32.5 ± 1.2 s-1, respectively (Szetlner et al., 2002).  
Human PEP 
When attempting to identify a potential inhibitor to spPEP, human PEP (hPEP) 
must be considered; belonging to the prolyl oligopeptidase family, hPEP shares 
similar conserved regions. Using the UCSF Chimera software (Petterson et al., 
2004) to compare the amino acid sequence of spPEP to the known structure of 
human PEP (Yandamuri et al., 2014) generated a 3-dimensional structure (Fig. 
1) that demonstrates the high level of conservation between mammalian and 
spPEP. Dysfunctional PEP has been linked to a variety of neurological diseases 
in mammals, including Alzheimer’s disease (AD), in which decreased PEP 
activity may lead to neuronal degeneration (Laitinen et al., 2001). More current 
research has controversially suggested that PEP inhibition is linked to Amyloid-β 
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accumulation, another potential factor in AD (Rossner et al., 2005). In previous 
research, hPEP has been shown to be selectively inhibited by peptides 
containing less than 30 amino acid residues; those greater than 30 did not bind 
(Polgar, 2000). Because of this, the hypothesis for this study is that recombinant 
peptides designed to be larger than 30 amino acids should bind and inhibit 
spPEP without affecting hPEP. 
Peptides from casein as potential inhibitors of PEP 
 In recent studies, peptides from Lactobacillus hydrolysates of caseins in 
bovine milk have been shown to inhibit hPEP in human colon cells (Juillerat-
Jeanneret et al., 2010). Since hPEP and spPEP share homology, this suggests 
that recombinant peptides will also inhibit spPEP.  It is suspected that the 
inhibition of PEP is size specific. Previous research has demonstrated that a 
partial digestion of whole casein, resulting in a pool of peptides of varying sizes, 
yielded an 87% inhibition of purified spPEP (Hargrove, 2013). 
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Figure 1: The predicted structural alignment of spPEP (blue) to the 
known crystalized structure of porcine PEP (tan) (Yandamuri et al., 
2014) using UCSF Chimera (Petterson et al., 2004). 
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MATERIALS AND METHODS 
 
Inserting hPEP into pLIC Vector and Transformation of JM109 E. coli strain. 
Transformation of JM109 with LIC Vector 
 Commercially competent E. coli JM109 cells (≥ 1 x 108 cfu/µg DNA, 
Promega, Corp.) (genotype: F′ (traD36, proAB+ lacI q, lacZ∆M15) endA1 recA1 
hsdR17(rk – ,mk + ) mcrA supE44 λ- gyrA96 relA1 ∆(lac-proAB) thi-1 lon) were 
obtained from the -80°C freezer and placed immediately in ice. Once thawed, the 
tubes were flicked gently to mix the cells. 10 ng of vector pNYCOMPS-LIC-
FH10T+ (pLIC) (Arizona State DNA Repository) DNA was transferred to chilled 
five 17 x 100mm round-bottom polypropylene culture tubes. To each tube, 50 µL 
of the cells was added. These were then gently flicked and placed on ice for 10 
minutes. The cells were then heat-shocked at 42°C for 45-50 seconds. The tubes 
were returned immediately to ice for 2 minutes. 400 µL of SOC medium (Fisher 
Scientific) was added to each tube, which was then incubated at 37°C for one 
hour with shaking at 200 rpm. Aliquots from each tube of 100 µL and 50 µL were 
spread in duplicate on kanamycin/chloramphenicol plates (50 µg/mL kanamycin, 
34 µg/mL chloramphenicol). The plates were then incubated overnight at 37°C. 
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Purification of LIC vector 
Eight kanamycin/chloramphenicol cultures were inoculated using 
individual colonies and incubated overnight at 37°C. For purification, a plasmid 
miniprep (ZymoPURE™ Plasmid Miniprep, cat. D4200/1, Zymo Research) was 
performed per manufacturer’s protocol on each culture. The purified plasmids 
were then stored at −20°C. 
Polymerase Chain Reaction of hPEP transformants 
 A PCR was performed using the gene specific primers listed in Table 1. 
JM109 E. coli cells were previously transformed with hPEP (obtained from GE 
Healthcare Dharmacon, Lafayette, CO). Ten individual bacterial colonies were 
selected and used as a template for a reaction. Colonies selected were first 
transferred to a grid plate using a pipette tip. The tip was then swirled in the PCR 
reaction buffer, transferring the remaining cells to the buffer. GoTaq DNA 
polymerase (Promega Corp., Madison, WI) was used for amplification. The PCR 
was performed using an iCycler thermal cycler (Bio-Rad Laboratories), using the 
reagents and parameters for the reaction listed in Table 2 and Table 3, 
respectively. Additionally, to optimize the annealing step, a temperature gradient 
(55-63°C) was established on the thermal cycler. Following amplification, 
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agarose gel electrophoresis (1% w/v) was used to screen the PCR products for 
verification. 
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Table 1: Forwards and reverse gene specific primers were used for the       
amplification of hPEP.  
Primer 
Name 
Sequence Tm 
hPEPLICfor 
5’-TATTTTAATCCTACGTAATGCT 
GTCCCTTCAGTACCCCGAC-3’ 
79.2°C 
hPEPLICrev 
5’-CCCTCAATATTATACGGGTCATTAT 
GGAATCCAGTCGACGTTCAGGCA-3’ 
83.7°C 
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Table 2: PCR reaction Mix. Reaction volumes were prepared at 50 µL for each 
tube. A total of 8 reactions were performed using separate bacterial colonies as 
the template. 
Reagents Volume (µL) 
10X GoTaq Buffer 5 
10µM dNTP Mix 2.5 
Forward Primer 10 µM 2.5 
Reverse Primer 10 µM 2.5 
GoTaq Polymerase 0.5 (1.5 U) 
diH2O 37 
10 
 
 
 
 
 
Table 3: PCR parameters for amplification of hPEP With Temperature Gradient   
Step Temperature (°C) Time  
 
 
 
35 
Cycles 
Initial Denaturation 95 4 min 
Denaturation 95 30 sec 
Annealing 55-63 30 sec 
Extension 68 3 min 
Polishing 
Extension 
72 10 min 
Hold 4 ∞ 
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Agarose Gel Electrophoresis 
 Agarose gel electrophoresis was used for all visualization of DNA 
plasmids, restriction enzyme products, and PCR amplicons. For comparison, 5 
µL Bionexus Hi-Lo™ DNA marker was added to one or two lanes in each gel. 
Bromophenol blue containing loading dye was added (5 µL) to 10 µL of each 
PCR product and these were loaded into individual lanes. The gel was run with 
1X TAE buffer (48.4 g Trizma base + 20 mL 0.5M EDTA, pH 8.0 + 11.4 mL glacial 
acetic acid) at 100 V for approximately 40 minutes. For visualization, ethidium 
bromide was added during the preparation of the gel. All gels were analyzed 
using a Typhoon FLA 9500 spectrophotometer (GE Healthcare). The volume 
remaining from the samples that were confirmed to contain hPEP were pooled 
and run on a separate preparative gel.  
Purification of PCR amplicons and restriction enzyme products 
 The bands corresponding to the amplified PCR products as well as 
products from restriction enzyme digestion were cut from the agarose gel and 
purified using Wizard® SV Gel and PCR Clean-Up System (Promega, Corp.) as 
per manufacturer’s protocol. 
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Measurement of DNA Concentration and Purity 
 Following purification of the DNA samples, the concentration was then 
measured using a Cary®50 UV-Vis spectrophotometer (Agilent Corp.). The 
machine was zeroed using the same eluent that was used during the plasmid 
purification, nuclease free water. The absorbance was then measured at A260 and 
A280. For purity, the [A260/A280] was determined.  
To calculate the concentration of DNA, the following formula was used: 
𝐷𝑁𝐴𝑑𝑠
  𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 = 50 
µg
mL
 𝑥 𝑂𝐷260 𝑥 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟
∗ 
*Using a 1 cm pathlength, the optical density at 260nm (OD260) is equal to 1.0 for 
a 50µg/mL solution of dsDNA (Barbas et al., 2007). 
Concentrating pLIC by Sodium Acetate and Ethanol Precipitation 
To perform the SnaBI restriction enzyme digestion of the pLIC to prepare 
it for the future insertion of hPEP, approximately 10 µg DNA was used. The 
measured pLIC was initially too dilute to accomplish the digestion at the desired 
volume, and therefor was concentrated. One tenth the pLIC volume of 3 M Na-
Acetate and 2x the pLIC volume of ice-cold 100% ethanol was added. This was 
mixed by flicking and left to incubate at -80°C for 30 minutes. After being allowed 
to chill, it was centrifuged at max speed for 15 minutes. The supernatant was 
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carefully decanted from the pellet. The remaining ethanol was evaporated and 
the pellet was re-suspended in 10 µL nuclease-free H2O. 
Restriction Enzyme Digestion of LIC Vector 
 A SnaBI (New England Biolabs, Ipswich, MA) restriction digestion was 
performed to linearize the LIC vector. The pLIC vector contains two restriction 
sites for SnaBI, located at 5313 bp and 6840 bp (Figure 2). The restriction 
digestion was prepared using 10 µg of pLIC DNA and 20 U SnaBI in a 50 µL 
reaction. The reaction components are listed in Table 4. The mixture was 
incubated at 37°C for a minimum of 2 hours. 10 µL of the digested and 20  µL 
undigested products were electrophoresed on an analytical 1% agarose gel for 
comparison. The remainder of the digested pLIC was run on a preparative gel.  
T4 DNA Polymerase Ligation 
The pLIC and hPEP were each treated with 3 U T4 DNA polymerase 
(3U/µL) to create complimentary overhangs on both the vector and the insert 
(Sambrook et al., 2001). In one tube, 500 ng hPEP was treated in the presence 
of dCTPs, producing an overhang on the insert. In a second tube, 500 ng pLIC 
was treated with T4 DNA polymerase in the presence of dGTPs to produce a 
complimentary overhang on the vector to the insert. The reaction components for 
the treatment are listed in Table 5. Both tubes were incubated for 30 minutes at 
room temperature. They were then incubated at 75°C for 20 minutes to inactivate 
14 
 
the polymerase. The insert and vector were then mixed at Vector:Insert 
molecular ratios of 1:1, 1:2.5, 1:5, and 1:5 in the presence of 50 µM EDTA. The 
mixtures were incubated at 75°C for 5 additional minutes and then mixed by 
flicking. They were allowed to anneal overnight at 4°C. 
15 
 
 
 
 
  
Figure 2: pNYCOMPS-LIC-FH10T+ (pLIC) (Arizona State DNA Repository) 
plasmid map, 6840 bp. A double digestion was performed using 20 Units of 
SnaBI, cutting out the chloramphenicol resistance segment of the vector 
(CmR). 
SnaBI 
SnaBI 
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Table 4: The reaction mixture for the digestion of pLIC is shown below. As a 
control, a sample of pLIC was also used in a reaction mix lacking the digestion 
enzyme. 
Reaction components Uncut Cut 
SnaBI (4U/µL) N/A 5 µL (20 Units) 
10x CutSmart® Buffer 
(NEB) 
2 µL 5 µL 
pLIC DNA 1 µL 8 µL 
diH2O 17 µL 32 µL 
Total Volume 20 µL 50 µL 
17 
 
 
 
 
 
 
 Table 5: T4 DNA Polymerase exonuclease activity was used to create 
complimentary overhangs on hPEP and pLIC.
Reaction 
components 
hPEP pLIC 
Sample DNA 500 ng 500 ng 
10x Buffer 3 µL 3 µL 
dCTP 100 μM - 
dGTP - 100 μM 
T4 Polymerase 3 U 3 U 
dH2O 4 µL 3 µL 
Total Volume 30 µL 30 µL 
18 
 
Transformation of JM109 With pLIC-hPEP 
 The tubes containing the ligation reactions were briefly centrifuged to 
collect the contents at the bottom. From each of the tubes, 2 µL were used to 
transform commercially competent E. coli JM109 cells (≥ 1 x 108 cfu/µg DNA, 
Promega, Corp.) via heat-shock as described previously. A tube containing 
JM109 cells was taken through the transformation protocol as a negative control. 
After the transformation, the cells were plated in duplicate at aliquots of 100 µL 
and 50 µL. The remaining volume was centrifuged, decanted, re-suspended, and 
then plated. To select for transformants, cells were plated in the presence of 
kanamycin (50mg/mL). Three control plates were also made. Two, containing 
only LB agar, were plated with the non-transformed JM109 cells. The final control 
plate was prepared with 50 μg/mL kanamycin and was plated with the same 
cells. 
Confirmation of Transformation by PCR and Gel Electrophoresis 
 Eighteen colonies were selected at random to be PCR screened for 
verification of hPEP insert as an indication of successful ligation and subsequent 
transformation. The colonies selected were also spot inoculated on a grid plate 
for later use. The previously described PCR reaction mix components and hPEP 
forward and reverse primers were used for the reaction. The parameters for the 
19 
 
thermal cycler are listed in Table 6. The amplified products were run on a 1% 
agarose gel for analysis. 
20 
 
 
 
 
 
 
 
Table 6: Parameters for PCR screening using colony picks from pLIC-hPEP 
transformed JM109 plates. 
Step Temperature 
(°C) 
Time  
 
 
 
 
 
 
 
 
35 
Cycles 
Initial 
Denaturation 
95 4 min 
Denaturation 95 30 sec 
Annealing 60 30 sec 
Extension 72 3 min 
Polishing 
Extension 
72 5 min 
Hold 4 ∞ 
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Maxiprep of pLIC-hPEP for sequencing 
 A 100-200 ng/µL plasmid concentration was required prior to sending the 
sequencing to Eurofins MWG Operon LLC. To achieve the required 
concentration, four colonies that were shown positive for hPEP were selected 
from the grid plate and used to inoculate individual Erlenmeyer flasks containing 
150 mL Super Broth II (Per liter: 32 g Tryptone, 20 g yeast extract, 5 g NaCl (s), 
and 1 g Trizma base (Sigma-Aldrich Co., St. Louis, MO, USA)). These were 
incubated overnight at 37°C with aeration. To purify the plasmid, a maxiprep 
(ZymoPURE™ Plasmid Maxiprep Kit, Cat. D4202, Zymo Research) was 
performed on each 150 mL culture. The concentration and purity of each plasmid 
sample was determined by measuring the A260 and A280, as described previously. 
The samples were then diluted to 100-200 ng/µL and sent off to Eurofins MWG 
Operon LLC. (Louisville, KY) for both forward and reverse sequencing using the 
previously described hPEP primers. 
Sequence Analysis 
 The resulting sequencing data was received as abi compatible files. 
CodonCode Aligner (Version 6.0.1., CodonCode Corporation, 2015) was used to 
remove any vector and non-reliable (low signal) sequence data. BioEdit (Hall T. 
A., 2013) was used to align the sequences via the sequence-nucleic acid-reverse 
compliment tool. A contig sequence was then built using the BioEdit Cap Contig 
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program on the aligned sequences. The contig sequence was submitted as a 
query to NCBI nucleotide-BLAST (Altschul et al., 1990). 
 
Transformation of BL21(DE3)+pTF-S with the pLIC-hPEP Construct and 
Subsequent Expression 
Inducing the Competency of BL21(DE3) + pTF-S 
 The host that was used for the expression of hPEP was BL21(DE3)pTF-S 
E. coli (Genotype: fhuA2 [lon] ompT gal (λ DE3) [dcm] ∆hsdS; λ DE3 = (λ 
sBamHIo ∆EcoRI-B int::(lacI::PlacUV5::T7 gene1) i21 ∆nin5) ). Prior to 
transforming the host with the hPEP construct, the cells were made competent 
using the calcium chloride/Tris buffer method (Mendel and Higa, 1970). Ten 
milliliters of LB broth (34 µg/mL chloramphenicol) was aliquoted into two 50 mL 
conical tubes. A glycerol stock of BL21(DE3)+pTF-S (Dareddy, V., 2012) cells 
were thawed on ice and then were mixed by flicking. Ten microliters of the stock 
was used to inoculate one of the conical tubes containing the 
LB/chloramphenicol. This was incubated overnight at 37°C with aeration. The 
following day, 10 µL of the culture was aliquoted into the remaining conical tube. 
This was cultivated at 37°C with aeration. The optical density at 600 nm was 
measured intermittently using a DU® 800 spectrophotometer (Beckman Coulter, 
Brea, CA, USA) until the culture reached an OD600 of ~0.6. The culture was 
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chilled on ice for 10 minutes and centrifuged for 5 minutes at 4000 x g, 4°C. The 
supernatant was aseptically decanted from the pellet. 25mL of sterile, ice-cold 
CaCl2 in Tris buffer (pH 8.0) was added to the pellet, which was then vortexed to 
resuspend. The cells were centrifuged using the same conditions as before. At 
this point, the cells were handled gently due to them being fragile from treatment. 
The supernatant was decanted from the tube carefully as to not dislodge the 
pellet. Five milliliters of ice-cold CaCl2-Tris buffer was added and the tube was 
gently swirled to resuspend the pellet. The cells, now competent for 
transformation, were dispensed into 1.5 mL microcentrifuge tubes, at 500 µL 
aliquots. Five hundred microliters of 70% glycerol was added to each tube 
followed by flash-freezing using liquid nitrogen and then stored at -80°C. 
Transformation of BL21(DE3)+pTF-S cells with pLIC-hPEP 
 A stock of freshly competent BL21(DE3)+pTF-S (Dareddy, 2012) cells was 
removed from -80°C storage and thawed on ice. While thawing, three 17x100mm 
round-bottom polypropylene culture tubes were labeled “1”, “2”, and “3”. Two 
microliters of the hPEP construct was added to Tube 2, while 5 µL was added to 
Tube 3. Tube 1 served as a control, to which no plasmid DNA was added. 50 µL 
of the BL21 cells was aliquoted into each tube. Each tube was subjected to the 
heat-shock method of transformation and plated as previously described in the 
transformation of JM109 with pLIC-hPEP. These plates consisted of LB agar, with 
50 µg/mL kanamycin and 34 µg/mL chloramphenicol to select for transformants. 
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Aliquots of 100 µL from Tube 1 were added to three plates containing only LB agar. 
The plates were incubated overnight at 37°C. Transformants were grid-plated and 
then screened by PCR and 1% agarose gel electrophoresis. 10 mL cultures (LB 
broth with chloramphenicol and kanamycin) were grown using the colonies that 
were confirmed to contain the hPEP construct. Glycerol stocks were prepared for 
each culture, flash-frozen using liquid NO2, and then stored at -80C°. 
Expression of hPEP 
 To express hPEP, a glycerol stock of the BL21(DE3)+pTF-S + pLIC-hPEP 
was first thawed on ice. A loop-full of the stock was used to inoculate 100mL of 
LB broth with 50 mg/mL kanamycin and 34 µg/mL chloramphenicol. This was 
incubated overnight at 37°C with aeration. The following day, 60 mL of the 
culture was used to inoculate 6 liters of 2x LB media containing the previous 
kanamycin and chloramphenicol concentrations. The 6L growth was performed 
using the BioFlow 110 Modular Fermentor & Bioreactor (New Brunswick 
Scientific Co., INC., Edison, NJ, USA). Heat was applied to the vessel by a heat 
jacket, the output of which was monitored and regulated by the system using a 
thermistor. The growth was kept at a constant 30°C. For aeration, O2 was added 
through a 0.22 µm filter by an air pump with the output for the mixer rotor kept at 
a constant 200 rpm. Prior to inoculation, a 3 mL sample was taken out as a 
blank. Once inoculated, the OD600 was measured every 30 minutes until it 
reached approximately 0.6. At this point, 10 mL removed from the culture was 
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incubated overnight at 37°C  to serve as an uninduced sample. The expression 
of the remaining culture was induced by adding IPTG to a final concentration of  
4 mM. The induced sample was allowed to continue growing overnight in the 
fermenter under the same conditions. 
 To harvest the induced cells, the culture was syphoned into 1 L centrifuge 
bottles and centrifuged in a swinging bucket rotor at 1250 x g for 30 minutes. The 
supernatant was decanted from each pellet. The pellets were stored overnight at 
-20°C to assist with cell lysis. The following day, the pellets were resuspended in 
50 to 75 mL of  0.1M sodium phosphate, pH 8.0, buffer. The pellets were pooled 
into a single 1 L bottle. Phosphate buffer was added to bring the total volume to 
500 mL. Ten milliliters of phosphate buffer was added to two vials of CelLytic™ 
Express (Sigma-Aldrich Co., St. Louis, MO, USA). These were added to the 
pooled lysate, which was then shaken vigorously and stored at -4°C for 4 hours. 
The pooled lysate was then pulse sonicated using a 60 Sonic Dismembrator 
(Fischer Scientific, Lafayette, CO, USA) at 1 second intervals for 1 minute to aid 
in lysis. The lysate was divided evenly into three 250 mL centrifuge bottles and 
centrifuged at 9300 x g for 30 minutes. The supernatant from each bottle was 
collected in a 1 L Erlenmeyer flask. TWEEN® 20 (Sigma-Aldrich Co., St. Louis, 
MO, USA) was added to the clarified lysate to a final concentration of 0.1% (v/v). 
A magnetic stir bar was placed in the flask followed by 5 mL Ni-NTA resin 
(Thermo Fisher Scientific, Waltham, MA, USA), pre-equilibrated with the 0.1M 
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phosphate buffer. The resin-lysate mixture was left spinning slowly overnight at 
4°C. 
 
Purification of hPEP with Ni Affinity Chromatography 
 The resin-lysate mixture was removed from 4°C and centrifuged at 9,300 x 
g to pellet the resin. The supernatant was carefully poured away from the pellet 
to remove as much as possible without losing any of the resin. A slurry was 
made of the enzyme-Ni resin which was transferred to an open column for 
column chromatography. An ÄKTA Protein Purification System (GE Healthcare 
Bio-Sciences, Pittsburgh, PA) was used in manual mode for the chromatography. 
The resin was washed using 120 mL of 0.1M phosphate buffer (pH 8.0) 
containing 0.1% TWEEN-20 to remove unbound contaminants. The enzyme was 
eluted using a linear gradient of increasing imidazole from 0 to 0.25 mM over 400 
mL total volume. Fractions of 5 mL were eluted at a flow rate of 1 mL/min. 
Concentration of Enzyme 
 The enzyme fractions were pooled and concentrated using a Centricep® 
Centrifugal filter device with an Ultracel® 50K membrane (EMD Millipore Corp., 
Billerica Massachusetts, USA). Fifteen mililiters of the sample was added to the 
device and centrifuged at 1,500 x g for 2 hours. The filtrate was decanted, and 
then more sample was added up to 15 mL total, followed by another round of 
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centrifugation. This was repeated as necessary to concentrate protein fractions 
for enzyme kinetic assays. 
Gly-Pro-pNA Assay 
 All obtained hPEP lysates were assayed to measure activity. The assay 
was performed in a 96-well microtiter plate, using a SoftMax® Pro 5 plate reader 
(SN# SMP500-05066-QAQD, Molecular Devices, LLC, Sunnyvale, CA). The 
components of the assay are listed in Table 7. Final concentrations of the 
individual components were 1x PBS, 0.3 mM GPpNA, and 0.1 M DTT in a 200µL 
microtiter assay. The absorbance at 410 nm was used to detect hydrolysis of the 
GPpNA. An absorption coefficient of 8800 L/mol•cm was used to convert the 
absorption to µmol of substrate cleaved. The assay was measured in kinetic 
mode using a SoftMax® Pro 5 plate reader (Molecular Devices, LLC) set at 37°C, 
collecting a measurement every 9 seconds over an hour.  
Due to low activity levels in one of the enzyme batches, different amounts 
of enzyme were also tested to determine optimum enzyme amounts to add to 
each assay. Table 8 lists the components of each of these assayst. 
 To determine Km and Vmax of the different samples of hPEP, standard 
assays were performed varying the amount of substrate present (Table 9). For 
the first enzyme batch, the final concentrations of substrate used were 0.3 mM, 
0.15 mM, 0.075 mM, 0.03 mM, 0.015 mM, and 0.0075mM. To determine the Km 
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and Vmax for the hPEP from the second enzyme batch, the final concentrations 
of the substrate were 0.3 mM, 0.15mM, 0.1 mM, 0.075 mM, 0.05 mM, and 0.0 
mM. The data for the assays were analyzed and used to produce a graph 
demonstrating the concentration of pNA released vs Time. Using linear 
regression, the slopes produced by the different substrate concentrations were 
recorded. These slopes correlate to the velocity (Vₒ) of the different reactions. 
Plotting the Vₒ versus concentration of substrate ([S]) produced a Michaelis-
Menton plot of the data. Plotting the inverse (1/Vₒ vs 1/[S]) produced the 
Lineweever-Burk Plot. The Km’s were calculated using linear regression to 
calculate the x-intercepts (x-int) for each assay. The Km is equal to 1/[X-int]. The 
Vmax can be calculated similarly by taking 1/[y-int] (Segel, 2014).
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Table 7: The standard reaction mixture components and volumes for a 
GPpNA microtiter assay are shown. The reaction volume for all wells   
was 200 µL and consisted of 100 µL enzyme   
 
1 Well 
50 Wells 100 Wells 
150 
Wells 
10x PBS 20 µL 1 mL 2 mL 3 mL 
3mM 
GPpNA 
20 µL 1 mL 2 mL 3 mL 
1M DTT 2 µL 100 µL 200 µL 300 µL 
diH2O 58 µL 2.9 mL 5.8 mL 6.7 mL 
Total 
Volume 
100 µL 5 mL 10 mL 15 mL 
Enzyme 
100 µL per 
Well    
Total Well 
Volume 
200 µL 
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Table 8: A GPpNA assay was performed using 3 different volumes of hPEP to 
determine the lowest amount of enzyme that can be used while still achieving 
high activity. hPEP was varied in increments of 50 µL. The volume of diH2O was 
adjusted to maintain a well volume of 200 µL. 
 
10x PBS 
(µL) 
3mM 
GPpNA 
(µL) 
1M DTT 
(µL) 
diH2O 
(µL) 
hPEP (µL) 
20 20 2 108 50 
20 20 2 58 100 
20 20 2 8 150 
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Table 9: GPpNA assays were conducted using hPEP isolated from two different 
expression experiments (A) and (B). The assays were run at 410 nm and the 
absorbance was measured every 9 seconds for 1 hour. The substrate 
concentration was varied, allowing for the determination of Km and Vmax by 
taking the slopes of the linear portions of graphs.   
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150 8 2 20 - 20 0.3 50 108 2 20 - 20 .3 
150 18 2 20 - 10 0.15 50 118 2 20 - 10 .15 
150 23 2 20 - 5 0.075 50 108 2 20 20 - .1 
150 8 2 20 20 - 0.03 50 113 2 20 15 - .075 
150 18 2 20 10 - .015 50 118 2 20 10 - .05 
150 23 2 20 5 - .007 50 128 2 20 0 - 0 
32 
 
Bradford Assay 
 To determine total protein content of each cell lysate, a Bradford assay 
(Bio-RAD., Herculus, CA, USA) was performed. Known concentrations of BSA 
from 0.6 µg/mL to 10.0 µg/mL were prepared with ultrapure BSA (1.0 mg/mL, 
Fischer Scientific, Lafayette, CO, USA). These known concentrations were 
assayed to plot the standard curve. BSA was added to the microtiter plate in the 
following amounts: 0.6 µg, 0.8 µg, 1.00 µg, 2 µg, 4 µg, 6 µg, 8 µg, and 10 µg. 
The total volume of each BSA sample was brought to 100 µL with 0.1M sodium 
phosphate buffer (pH 8.0). Dilutions were made for each of the cell lysates to 
1/100 and 1/1000. From both dilutions of each sample, volumes of 10 µL, 5 µL, 
and 2 µL were added to the microtiter plate in duplicate. The total volume was 
brought to 100 µL with 0.1M buffer. Ninety microliters of the 0.1M buffer and 10 
µL diH2O were added to one well as a blank. To all wells, 100 µL of 2x Bradford 
reagent (Bio-RAD, Herculus, CA, USA) was added and mixed by pipetting up 
and down carefully to prevent introducing air bubbles. In instances where air 
bubbles occurred, the plate was centrifuged for 1 minute at 3000 x g. The 
absorbance at 595 nm was measured using a SoftMax® Pro 5 plate reader (SN# 
SMP500-05066-QAQD, Molecular Devices, LLC, Sunnyvale, CA). The total 
protein concentration for each sample was calculated using the linear portion 
from the standard curve and correcting for dilution. 
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SDS-PAGE Analysis 
 To determine the purity of expressed hPEP, sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE) was used on both lysates 
demonstrating enzyme activity. A standard Laemmli SDS-PAGE (He, F., 2011) 
was performed using a 10% resolving gel and a 4% stacking gel. These gels 
were handcrafted using the components listed in Table 10. Ten micrograms total 
protein for each hPEP sample (as determined using the standard curve from the 
Bradford assay) was added to 1.5 mL microfuge tubes. Five microliters of sample 
loading dye was added to each, followed by denaturation at 95°C for 2 minutes. 
A 10 µL sample of Precision Plus Protein™ Standards (Bio-RAD., Herculus, CA, 
USA) was subjected to denaturation as well. The samples and standard were 
loaded into individual lanes and electrophoresis was performed at 100 V for 1 
hour. For visualization, the gel was stained in a solution containing 0.25% 
Coomassie Blue (Bio-RAD., Herculus, CA, USA). The staining process took 
place overnight at room temperature while rocking. The gel was destained using 
50% methanol, and 10% glacial acetic acid in H2O.
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 Table 10: Standard Laemmli SDS PAGE Gel Recipe (He, F., 2011). The 
components for preparing the resolving and stacking parts of an SDS PAGE    
gel are shown. Both were prepared in different 50 mL conical tubes. 
 
 
 
 
 
 
 
 
10% Resolving: 29.2% acrylamide + 0.8% bis 5 mL 
 1.5 M Tris-HCl, pH 8.86 3.75 mL 
 diH2O 6.25 mL 
 10% SDS 150 µL 
(When ready to 
polymerize) 
10% APS 70 µL 
TEMED 7 µL 
4% Stacking: 29.2% acrylamide + 0.8% bis 2 mL 
 1.5 M Tris-HCl, pH 8.86 3.78 mL 
 diH2O 9.1 mL 
 10% SDS 150 µL 
(When ready to 
polymerize) 
10% APS 70 µL 
TEMED 14 µL 
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RESULTS 
 
 The overall goal of the project was to clone and express hPEP in the 
same host as spPEP. The first part of the project included the cloning, 
purification, and restriction digestion of the pLIC vector and the subsequent 
ligation of it to PCR amplified hPEP; this construct was cloned into JM109 E. coli 
cells. The second objective of this project was cloning and transforming the pLIC-
hPEP construct into the final E. coli expression host BL21(DE3)+pTF-S cells. The 
final part of the project involved the expression and partial purification of hPEP 
and the subsequent analysis of the enzyme’s kinetics. 
 
PCR Amplified hPEP Products 
 Gene specific primers were used to amplify hPEP, using 10 colonies 
transformed with hPEP as the template for the reaction. A temperature gradient 
from 55-63°C was established for the annealing step of the reaction. The 
amplified products were loaded on a 1% agarose gel for analysis (Figure 3). All 
lanes demonstrated the expected ~2133 bp band except gel A-lane 6, 
corresponding to a 63°C annealing temperature. The hPEP products were 
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pooled and loaded on a preparative 1% agarose gel to purify the amplified hPEP 
products (Figure 4). The resulting band was cut out and purified using Wizard®  
SV Gel and PCR Clean-Up System (Promega, Corp.). The weight of the gel slice 
corresponding to hPEP was 441mg. 
Purification of pLIC 
 The pLIC was transformed into a JM109 E. coli cell line. The plasmid was 
then purified using a ZymoPURE™ Plasmid Miniprep (cat. D4200/1, Zymo 
Research). The purified pLIC and hPEP product were loaded onto a 1% agarose 
gel (Figure 5). The concentration and purity of both samples were determined by 
measuring the A260 and A280 with a Cary®50 UV-Vis spectrophotometer (Varian, 
Inc.). The final measurements, included calculated purity and concentration, are 
listed in Table 11. The average concentration for the hPEP samples was        
28.0 ng/µL, whereas the average for the pLIC was 46.25 ng/µL. 
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Figure 3:  Amplified hPEP products from PCR using individual colonies as 
template on a 1% agarose gel. Ten colonies transformed with hPEP were 
selected as the template for the reaction. A temperature gradient from 55-63°C 
was established for the annealing step of the reaction. On the first gel (A), lanes 
1 through 5 exhibited a band of ~2133bp. The band in lane 5 was noticeably 
lighter than the others. For the different samples, the annealing temperatures 
from the gradient are as follows: Gel A Lane 1 – 57.3°C, lane 2 – 58.4°C, lane 3 
– 59.5°C, lane 4 – 60.6°C, lane 5 – 61.8°C, lane 6 - 63°C; Gel B Lane 1 - 55°C, 
lane 2 - 55°C, lane 3 - 55°C, lane 4 – 56.3°C. M represents Bionexus Hi-Lo™ 
DNA marker. 
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Figure 4: Preparative gel of pooled samples of amplified hPEP. The 
remaining volume from the samples confirmed to contain hPEP (those that 
exhibited a ~2133 bp band on the analytical gels) were pooled. This was run on  
a 1% agarose gel. A single band of (~2133 bp) is visible under the lane marked 
hPEP. This band was excised and purified using Wizard® SV Gel and PCR 
Clean-Up System (Promega, Corp.). M represents Bionexus Hi-Lo™ DNA 
marker. 
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Figure 5: Results of the clean up of LIC vector and the gel purification of 
hPEP. The bands were separated on a 1% (w/v) agarose gel in 1X TAE buffer at 
100V for 40 minutes. The positions of both hPEP are at the desired approximate 
2133 bp. The pLIC bands are consistent with that of undigested plasmids, each 
band resulting from the different plasmid conformations. M represents Bionexus 
Hi-Lo™ DNA marker. 
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Table 11: The concentration and purity of the cleaned up LIC vector and 
amplified hPEP are shown below. 
 
Sample A260 A280 Concentration 
(ng/µL) 
Purity 
(A260/A280) 
hPEP1 0.56 0.31 28.0 1.81 
hPEP2 0.56 0.30 28.0 1.87 
LIC Vector1 1.0 0.55 50.0 1.81 
LIC Vector2 0.85 0.47 42.5 1.81 
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SnaBI Restriction Digestion of pLIC 
 A restriction digestion was performed on the pLIC vector using SnaBI 
enzyme. pLIC contains two restriction sites for SnaBI, resulting in two linear 
fragments when loaded on an agarose gel. This is demonstrated in Figure 6, 
where a sample of the SnaBI digestion of pLIC was loaded side-by-side to an 
undigested sample of pLIC for comparison. The digested sample was comprised 
of two primary fragments: ~1527 bp and ~5313 bp. The remaining volume of the 
digested sample was loaded onto a preparative 1% agarose gel (Figure 7). The 
~5313 bp fragment was excised and purified using Wizard® SV Gel and PCR 
Clean-Up System (Promega, Corp.). The gel slice was measured to be 649 mg. 
Following the purification of the digested pLIC, a sample was loaded onto a 1% 
agarose gel to verify that no other bands were present. Figure 8 demonstrates a 
single band at ~5313 bp. No other bands were visible. 
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Figure 6: Analysis of double SnaBI digestion of pLIC on 1% agarose gel. 
The restriction digestion was prepared using 8 µL of pLIC DNA and 5 µL SnaBI 
in a 50 µL reaction. The mixture was incubated at 37°C for a minimum of 2 hours. 
Digested and Undigested were run side-by-side for comparison. Lane (1) shows 
pLIC digested with SnaBI; two primary bands are visible: (A) the 5313 bp 
fragment and (B) the 1527 bp fragment. Lane (2) shows the undigested plasmid. 
M represents Bionexus Hi-Lo™ DNA marker.  
A 
B 
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Figure 7: Preparative agarose gel (1%) of double SnaBI digestion of pLIC. In 
order to purify and excise the desired pLIC 5313 bp band (A), a 1% agarose 
preparative gel was run using the remainder of the digestion reaction mix. (B) 
The lower band represents the resulting dropout from the double digestion of 
pLIC (1527 bp). M represents Bionexus Hi-Lo™ DNA marker. 
  
A 
B 
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Figure 8: Cleaned up pLIC 5313 bp band on agarose gel (1%). The 
5313 bp band was excised from the analytical gel (weighing 649 mg) 
and purified using Wizard® SV Gel and PCR Clean-Up System 
(Promega, Corp.). The product was then run on a 1% agarose gel for 
verification. The encircled single band above shows the desired 5313 
bp band of the digested pLIC. M represents Bionexus Hi-Lo™ DNA 
marker. 
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Transformation of JM109 with pLIC-hPEP Construct 
 Complimentary overhangs were created on hPEP and the linearized pLIC. 
These were mixed at Vector:Insert molecular ratios of 1:1, 1:2.5, 1:5, and 1:5 in 
the presence of 50 µMol EDTA. After the insert and vector were allowed to 
anneal overnight, the resulting pLIC-hPEP construct was used to transform a 
JM109 E. coli cell line. The cells were plated in duplicate at aliquots of 100 µL 
and 50 µL; the remaining volume was centrifuged, decanted, re-suspended, and 
then plated. The number of colonies that grew after the transformation were 
recorded and are listed in Table 12. The positive control plates grew lawns as 
expected, indicating the cells remained viable throughout the transformation. The 
negative control demonstrated no growth, indicating the selective agent 
(kanamycin) functioned as desired. The vector to insert ratio that demonstrated 
the highest number of transformants, and therefore most successful ligation 
independent cloning, was the 1:1 mol sample. 18 colonies were selected at 
random and screened by PCR for verification using the previously described 
hPEP forward and reverse primers. These samples were loaded onto a 1% 
agarose gel for analysis (Figure 9). Of the 18 colonies screened, the expected 
2133bp band for hPEP was present in 11 samples. In the first gel (fig. 9, A), 
lanes 1 and 7 show bands at (~2133bp), while lanes 2 – 6 failed show the 
presence of amplified hPEP. On the second gel (fig. 9, B), lanes 1 and 4 
contained bands at (~2133bp), whereas this band was absent in lanes 2, 3, 5, 
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and 6. They can likely be explained as being false positive transformants. In the 
preparation of the plates, only 10 of the plates were made by adding the 
antibiotic prior to solidification of the agar. The other 10 plates had the antibiotic 
spread over the surface, and as of such, certain areas of the agar surface may 
have not been treated with the antibiotic. Without the selective agent present 
throughout, it is possible that the colony that grew either kicked out the pLIC-
hPEP or it never actually contained it in the first place. Within the final gel (fig 9, 
B), all seven sample lanes showed a band at (~2133bp).
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Table 12: CFU count of JM109 transformed with pLIC-hPEP. 500 ng hPEP 
was treated with 1 µL T4 DNA polymerase in the presence of 1 µL dCTP to 
create the overhang on the insert. To create the overhang on the vector, 500 ng 
pLIC was likewise treated with 1 µL T4 DNA polymerase in the presence of 
dGTPs. The vector and insert were then mixed at varying molar ratios (1:1, 1:2.5, 
1:5, and 1:5 in the presence of 50 µMol EDTA). These were then incubated at 
75°C for 5 minutes, mixed, and stored over night at 4°C. The following day, these 
mixtures were used to transform JM109 cells via heat shock. The cells were 
plated at varying volumes (100 µL and 50 µL in duplicate, and the remaining 
volume was plated after being centrifuged, decanted, and resuspended). They 
were plated in the presence of kanamycin (50mg/mL) to select for transformants. 
The plates were then incubated at 37°C overnight. The table above shows the 
number of successful transformants per vector to insert ratio and per volume 
plated. 
  
 
Sample 
(V:I)→ 
Volume ↓ 
1:1 1:2.5 1:5 
1:5  +  
50µMol 
EDTA 
100 µL 13 4 2 3 
100 µL 12 8 2 3 
50 µL 11 No Growth 1 1 
50 µL 7 2 No Growth 5 
Resuspended 22 4 5 2 
Positive Control 1 Positive Control 2 Negative Control 
LAWN LAWN No growth 
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Figure 9: PCR screening using colony picks from pLIC-hPEP transformed 
JM109 plates as DNA template and analysis by 1% agarose gel 
electrophoresis. Colonies were selected at random to be PCR screened for 
verification of hPEP insert as an indication of successful ligation and subsequent 
transformation. The colonies selected were also spot inoculated on a grid plate 
for later use. The previously described hPEP forward and reverse primers were 
used for the reaction. The amplified products were run on 1% agarose gels for 
analysis. Of the 18 colonies screened, the expected 2133 bp band for hPEP was 
present in 11 samples. (A) In the first gel, lanes 1 and 7 show bands at 
(~2133bp), while lanes 2 – 6 failed show the presence of amplified hPEP. (B) On 
the second gel, lanes 1 and 4 contained bands at (~2133bp), whereas this band 
was absent in lanes 2, 3, 5, and 6. (C) Within the final gel, all seven sample lanes 
showed a band at (~2133bp). M represents Bionexus Hi-Lo™ DNA marker. 
Interestingly, sample lanes B4 and C1-7 exhibited much darker bands than the 
others, indicating excessive template DNA being used during the PCR 
amplification. 
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Cloning and Purification of pLIC-hPEP  
Four colonies on the grid-plate corresponding to successful transformants 
were used to inoculate separate Erlenmeyer flasks containing 150 mL Super 
Broth II. A ZymoPURE™ Plasmid Maxiprep Kit (Cat. D4202, Zymo Research) 
was performed on the cultures to purify the pLIC-hPEP construct. During the cell 
pelleting step of the maxiprep, it was noticed that the pellet for culture 4 was 
significantly smaller than the 3 other samples (2.4 cm compared to 3.2 cm). The 
concentration and purity of the plasmid from each sample was determined by 
measuring the A260 and A280 (Table 13). The acceptable A260/280 measurement for 
a pure DNA sample is ~1.8 - 2.0 (Sambrook and Russell, 2001). Cultures 1 
through 3 had DNA concentrations of 500, 640, and 740 ng/µL, respectively. 
Culture 4 had a much smaller concentration of 160 ng/µL. All four cultures were 
within the acceptable range for purity. This is likely related to the cell pellet size 
previously mentioned. The first three samples were diluted to 100-200ng/µL and 
sent off along with the previously described hPEP forward and reverse primers to 
Eurofins MWG Operon LLC for Sanger Sequencing.
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Table 13: The concentration and purity of the pLIC-hPEP plasmid, post 
maxiprep, are shown below. Each of the samples was diluted by a factor of 20 
to achieve accurate measurements. The absorbance values are shown below. 
 
Sample A260 A280 
Concentration 
(ng/µL) 
Purity 
(A260/A280) 
Colony 1 
Colony 2 
10.0 
12.8 
4.8 
6.8 
500 
640 
2.08 
1.88 
Colony 3 
Colony 4 
14.8 
3.21 
8.0 
1.58 
740 
160 
1.85 
2.03 
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Sequence Analysis 
 The resulting sequencing data was sent as ab1 compatible files. The 
sequences were first cleaned up using CodonCode Aligner and then aligned with 
BioEdit to form a contig sequence. The contig sequence was subjected to a 
nucleotide-BLAST on the NCBI database. The BLAST result of the hPEP contig 
sequence yielded a 99.9% identity with Homo sapiens prolyl endopeptidase from 
the NCBI database. The contig sequence and the sequence corresponding to the 
highest identity match were aligned using http://www.fr33.net/translator.php to 
identify where disparities occurred between the two sequences. Figure 10 shows 
the nucleotide and amino acid sequence for the contig sequence (fig 10, A) and 
for the sequence of Homo sapiens prolyl endopeptidase from the NCBI database 
(fig 10, B). The alignment for the contig and hPEP cDNA from the NCBI database 
are shown in appendix A. Only two locations contained mismatches between the 
sequences. The first difference occurred at 1576 bp. Here, the sequence from 
the database contained a thymine, whereas the contig contained a cytosine. This 
change also resulted in a single amino acid variation between the query and 
subject sequences. The single nucleotide change resulted in the change of a 
positively charged Arg526 in the subject sequence to a polar Cys526 in the 
contig sequence. The second difference in sequences occurred at 2091 bp, 
where a guanine existed in the sequence from the database and adenine existed 
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in the contig sequence. This variation did not have an impact on the amino acid 
sequence, resulting in a conserved Ala697. 
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Figure 10: BLAST result of hPEP contig sequence yielded a 99.9% identity with Homo sapiens prolyl 
endopeptidase from the NCBI database. Changes in nucleotides were shown in bold. A is the contig (query) 
sequence, whereas B (see next page) is the subject sequence. The sequences were aligned to determine 
the location of mismatched bases (http://www.fr33.net/translator.php). 
 
ATGCTGTCCCTTCAG TACCCCGACGTGTAC CGCGACGAGACCGCC GTACAGGATTATCAT GGTCATAAAATTTGT 
 M  L  S  L  Q   Y  P  D  V  Y   R  D  E  T  A   V  Q  D  Y  H   G  H  K  I  C  
GACCCTTACGCCTGG CTTGAAGACCCCGAC AGTGAACAGACTAAG GCCTTTGTGGAGGCC CAGAATAAGATTACT 
 D  P  Y  A  W   L  E  D  P  D   S  E  Q  T  K   A  F  V  E  A   Q  N  K  I  T  
GTGCCATTTCTTGAG CAGTGTCCCATCAGA GGTTTATACAAAGAG AGAATGACTGAACTA TATGATTATCCCAAG 
 V  P  F  L  E   Q  C  P  I  R   G  L  Y  K  E   R  M  T  E  L   Y  D  Y  P  K  
TATAGTTGCCACTTC AAGAAAGGAAAACGG TATTTTTATTTTTAC AATACAGGTTTGCAG AACCAGCGAGTATTA 
 Y  S  C  H  F   K  K  G  K  R   Y  F  Y  F  Y   N  T  G  L  Q   N  Q  R  V  L  
TATGTACAGGATTCC TTAGAGGGTGAGGCC AGAGTGTTCCTGGAC CCCAACATACTGTCT GACGATGGCACAGTG 
 Y  V  Q  D  S   L  E  G  E  A   R  V  F  L  D   P  N  I  L  S   D  D  G  T  V  
GCACTCCGAGGTTAT GCGTTCAGCGAAGAT GGTGAATATTTTGCC TATGGTCTGAGTGCC AGTGGCTCAGACTGG 
 A  L  R  G  Y   A  F  S  E  D   G  E  Y  F  A   Y  G  L  S  A   S  G  S  D  W  
GTGACAATCAAGTTC ATGAAAGTTGATGGT GCCAAAGAGCTTCCA GATGTGCTTGAAAGA GTCAAGTTCAGCTGT 
 V  T  I  K  F   M  K  V  D  G   A  K  E  L  P   D  V  L  E  R   V  K  F  S  C  
ATGGCCTGGACCCAT GATGGGAAGGGAATG TTCTACAACTCATAC CCTCAACAGGATGGA AAAAGTGATGGCACA 
 M  A  W  T  H   D  G  K  G  M   F  Y  N  S  Y   P  Q  Q  D  G   K  S  D  G  T  
GAGACATCTACCAAT CTCCACCAAAAGCTC TACTACCATGTCTTG GGAACCGATCAGTCA GAAGATATTTTGTGT 
 E  T  S  T  N   L  H  Q  K  L   Y  Y  H  V  L   G  T  D  Q  S   E  D  I  L  C  
GCTGAGTTTCCTGAT GAACCTAAATGGATG GGTGGAGCTGAGTTA TCTGATGATGGCCGC TATGTCTTGTTATCA 
 A  E  F  P  D   E  P  K  W  M   G  G  A  E  L   S  D  D  G  R   Y  V  L  L  S  
ATAAGGGAAGGATGT GATCCAGTAAACCGA CTCTGGTACTGTGAC CTACAGCAGGAATCC AGTGGCATCGCGGGA 
 I  R  E  G  C   D  P  V  N  R   L  W  Y  C  D   L  Q  Q  E  S   S  G  I  A  G  
ATCCTGAAGTGGGTA AAACTGATTGACAAC TTTGAAGGGGAATAT GACTACGTGACCAAT GAGGGGACGGTGTTC 
 I  L  K  W  V   K  L  I  D  N   F  E  G  E  Y   D  Y  V  T  N   E  G  T  V  F  
ACATTCAAGACGAAT CGCCAGTCTCCCAAC TATCGCGTGATCAAC ATTGACTTCAGGGAT CCTGAAGAGTCTAAG 
 T  F  K  T  N   R  Q  S  P  N   Y  R  V  I  N   I  D  F  R  D   P  E  E  S  K  
TGGAAAGTACTTGTT CCTGAGCATGAGAAA GATGTCTTAGAATGG ATAGCTTGTGTCAGG TCCAACTTCTTGGTC 
 W  K  V  L  V   P  E  H  E  K   D  V  L  E  W   I  A  C  V  R   S  N  F  L  V  
TTATGCTACCTCCAT GACGTCAAGAACATT CTGCAGCTCCATGAC CTGACTACTGGTGCT CTCCTTAAGACCTTC 
 L  C  Y  L  H   D  V  K  N  I   L  Q  L  H  D   L  T  T  G  A   L  L  K  T  F  
CCGCTCGATGTCGGC AGCATTGTAGGGTAC AGCGGTCAGAAGAAG GACACTGAAATCTTC TATCAGTTTACTTCC 
 P  L  D  V  G   S  I  V  G  Y   S  G  Q  K  K   D  T  E  I  F   Y  Q  F  T  S  
TTTTTATCTCCAGGT ATCATTTATCACTGT GATCTTACCAAAGAG GAGCTGGAGCCAAGA GTTTTCCGAGAGGTG 
 F  L  S  P  G   I  I  Y  H  C   D  L  T  K  E   E  L  E  P  R   V  F  R  E  V  
ACCGTAAAAGGAATT GATGCTTCTGATTAC CAGACAGTCCAGATT TTCTACCCTAGCAAG GATGGTACGAAGATT 
 T  V  K  G  I   D  A  S  D  Y   Q  T  V  Q  I   F  Y  P  S  K   D  G  T  K  I  
CCAATGTTCATTGTG CATAAAAAAGGCATA AAATTGGATGGCTCT CATCCAGCTTTCTTA TATGGCTATGGCGGC 
 P  M  F  I  V   H  K  K  G  I   K  L  D  G  S   H  P  A  F  L   Y  G  Y  G  G  
TTCAACATATCCATC ACACCCAACTACAGT GTTTCCAGGCTTATT TTTGTGAGACACATG GGTGGTATCCTGGCA 
 F  N  I  S  I   T  P  N  Y  S   V  S  R  L  I   F  V  R  H  M   G  G  I  L  A  
GTGGCCAACATCAGA GGAGGTGGCGAATAT GGAGAGACGTGGCAT AAAGGTGGTATCTTG GCCAACAAACAAAAC 
 V  A  N  I  R   G  G  G  E  Y   G  E  T  W  H   K  G  G  I  L   A  N  K  Q  N  
CGCTTTGATGACTTT CAGTGTGCTGCTGAG TATCTGATCAAGGAA GGTTACACATCTCCC AAGAGGCTGACTATT 
 C  F  D  D  F   Q  C  A  A  E   Y  L  I  K  E   G  Y  T  S  P   K  R  L  T  I  
AATGGAGGTTCAAAT GGAGGCCTCTTAGTG GCTGCTTGTGCAAAT CAGAGACCTGACCTC TTTGGTTGTGTTATT 
 N  G  G  S  N   G  G  L  L  V   A  A  C  A  N   Q  R  P  D  L   F  G  C  V  I  
GCCCAAGTTGGAGTA ATGGACATGCTGAAG TTTCATAAATATACC ATCGGCCATGCTTGG ACCACTGATTATGGG 
 A  Q  V  G  V   M  D  M  L  K   F  H  K  Y  T   I  G  H  A  W   T  T  D  Y  G  
TGCTCGGACAGCAAA CAACACTTTGAATGG CTTGTCAAATACTCT CCATTGCATAATGTG AAGTTACCAGAAGCA 
 C  S  D  S  K   Q  H  F  E  W   L  V  K  Y  S   P  L  H  N  V   K  L  P  E  A  
GATGACATCCAGTAC CCGTCCATGCTGCTC CTCACTGCTGACCAT GATGACCGCGTGGTC CCGCTTCACTCCCTG 
 D  D  I  Q  Y   P  S  M  L  L   L  T  A  D  H   D  D  R  V  V   P  L  H  S  L  
AAGTTCATTGCCACC CTTCAGTACATCGTG GGCCGCAGCAGGAAG CAAAGCAACCCCCTG CTTATCCACGTGGAC 
 K  F  I  A  T   L  Q  Y  I  V   G  R  S  R  K   Q  S  N  P  L   L  I  H  V  D  
ACCAAGGCGGGCCAC GGGGCGGGGAAGCCC ACAGCCAAAGTGATA GAGGAAGTCTCAGAC ATGTTTGCATTCATC 
 T  K  A  G  H   G  A  G  K  P   T  A  K  V  I   E  E  V  S  D   M  F  A  F  I  
GCGCGGTGCCTGAAC GTCGACTGGATTCCA TAA 
 A  R  C  L  N   V  D  W  I  P   * 
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ATGCTGTCCCTTCAG TACCCCGACGTGTAC CGCGACGAGACCGCC GTACAGGATTATCAT GGTCATAAAATTTGT 
 M  L  S  L  Q   Y  P  D  V  Y   R  D  E  T  A   V  Q  D  Y  H   G  H  K  I  C  
GACCCTTACGCCTGG CTTGAAGACCCCGAC AGTGAACAGACTAAG GCCTTTGTGGAGGCC CAGAATAAGATTACT 
 D  P  Y  A  W   L  E  D  P  D   S  E  Q  T  K   A  F  V  E  A   Q  N  K  I  T  
GTGCCATTTCTTGAG CAGTGTCCCATCAGA GGTTTATACAAAGAG AGAATGACTGAACTA TATGATTATCCCAAG 
 V  P  F  L  E   Q  C  P  I  R   G  L  Y  K  E   R  M  T  E  L   Y  D  Y  P  K  
TATAGTTGCCACTTC AAGAAAGGAAAACGG TATTTTTATTTTTAC AATACAGGTTTGCAG AACCAGCGAGTATTA 
 Y  S  C  H  F   K  K  G  K  R   Y  F  Y  F  Y   N  T  G  L  Q   N  Q  R  V  L  
TATGTACAGGATTCC TTAGAGGGTGAGGCC AGAGTGTTCCTGGAC CCCAACATACTGTCT GACGATGGCACAGTG 
 Y  V  Q  D  S   L  E  G  E  A   R  V  F  L  D   P  N  I  L  S   D  D  G  T  V  
GCACTCCGAGGTTAT GCGTTCAGCGAAGAT GGTGAATATTTTGCC TATGGTCTGAGTGCC AGTGGCTCAGACTGG 
 A  L  R  G  Y   A  F  S  E  D   G  E  Y  F  A   Y  G  L  S  A   S  G  S  D  W  
GTGACAATCAAGTTC ATGAAAGTTGATGGT GCCAAAGAGCTTCCA GATGTGCTTGAAAGA GTCAAGTTCAGCTGT 
 V  T  I  K  F   M  K  V  D  G   A  K  E  L  P   D  V  L  E  R   V  K  F  S  C  
ATGGCCTGGACCCAT GATGGGAAGGGAATG TTCTACAACTCATAC CCTCAACAGGATGGA AAAAGTGATGGCACA 
 M  A  W  T  H   D  G  K  G  M   F  Y  N  S  Y   P  Q  Q  D  G   K  S  D  G  T  
GAGACATCTACCAAT CTCCACCAAAAGCTC TACTACCATGTCTTG GGAACCGATCAGTCA GAAGATATTTTGTGT 
 E  T  S  T  N   L  H  Q  K  L   Y  Y  H  V  L   G  T  D  Q  S   E  D  I  L  C  
GCTGAGTTTCCTGAT GAACCTAAATGGATG GGTGGAGCTGAGTTA TCTGATGATGGCCGC TATGTCTTGTTATCA 
 A  E  F  P  D   E  P  K  W  M   G  G  A  E  L   S  D  D  G  R   Y  V  L  L  S  
ATAAGGGAAGGATGT GATCCAGTAAACCGA CTCTGGTACTGTGAC CTACAGCAGGAATCC AGTGGCATCGCGGGA 
 I  R  E  G  C   D  P  V  N  R   L  W  Y  C  D   L  Q  Q  E  S   S  G  I  A  G  
ATCCTGAAGTGGGTA AAACTGATTGACAAC TTTGAAGGGGAATAT GACTACGTGACCAAT GAGGGGACGGTGTTC 
 I  L  K  W  V   K  L  I  D  N   F  E  G  E  Y   D  Y  V  T  N   E  G  T  V  F  
ACATTCAAGACGAAT CGCCAGTCTCCCAAC TATCGCGTGATCAAC ATTGACTTCAGGGAT CCTGAAGAGTCTAAG 
 T  F  K  T  N   R  Q  S  P  N   Y  R  V  I  N   I  D  F  R  D   P  E  E  S  K  
TGGAAAGTACTTGTT CCTGAGCATGAGAAA GATGTCTTAGAATGG ATAGCTTGTGTCAGG TCCAACTTCTTGGTC 
 W  K  V  L  V   P  E  H  E  K   D  V  L  E  W   I  A  C  V  R   S  N  F  L  V  
TTATGCTACCTCCAT GACGTCAAGAACATT CTGCAGCTCCATGAC CTGACTACTGGTGCT CTCCTTAAGACCTTC 
 L  C  Y  L  H   D  V  K  N  I   L  Q  L  H  D   L  T  T  G  A   L  L  K  T  F  
CCGCTCGATGTCGGC AGCATTGTAGGGTAC AGCGGTCAGAAGAAG GACACTGAAATCTTC TATCAGTTTACTTCC 
 P  L  D  V  G   S  I  V  G  Y   S  G  Q  K  K   D  T  E  I  F   Y  Q  F  T  S  
TTTTTATCTCCAGGT ATCATTTATCACTGT GATCTTACCAAAGAG GAGCTGGAGCCAAGA GTTTTCCGAGAGGTG 
 F  L  S  P  G   I  I  Y  H  C   D  L  T  K  E   E  L  E  P  R   V  F  R  E  V  
ACCGTAAAAGGAATT GATGCTTCTGATTAC CAGACAGTCCAGATT TTCTACCCTAGCAAG GATGGTACGAAGATT 
 T  V  K  G  I   D  A  S  D  Y   Q  T  V  Q  I   F  Y  P  S  K   D  G  T  K  I  
CCAATGTTCATTGTG CATAAAAAAGGCATA AAATTGGATGGCTCT CATCCAGCTTTCTTA TATGGCTATGGCGGC 
 P  M  F  I  V   H  K  K  G  I   K  L  D  G  S   H  P  A  F  L   Y  G  Y  G  G  
TTCAACATATCCATC ACACCCAACTACAGT GTTTCCAGGCTTATT TTTGTGAGACACATG GGTGGTATCCTGGCA 
 F  N  I  S  I   T  P  N  Y  S   V  S  R  L  I   F  V  R  H  M   G  G  I  L  A  
GTGGCCAACATCAGA GGAGGTGGCGAATAT GGAGAGACGTGGCAT AAAGGTGGTATCTTG GCCAACAAACAAAAC 
 V  A  N  I  R   G  G  G  E  Y   G  E  T  W  H   K  G  G  I  L   A  N  K  Q  N  
TGCTTTGATGACTTT CAGTGTGCTGCTGAG TATCTGATCAAGGAA GGTTACACATCTCCC AAGAGGCTGACTATT 
 R  F  D  D  F   Q  C  A  A  E   Y  L  I  K  E   G  Y  T  S  P   K  R  L  T  I  
AATGGAGGTTCAAAT GGAGGCCTCTTAGTG GCTGCTTGTGCAAAT CAGAGACCTGACCTC TTTGGTTGTGTTATT 
 N  G  G  S  N   G  G  L  L  V   A  A  C  A  N   Q  R  P  D  L   F  G  C  V  I  
GCCCAAGTTGGAGTA ATGGACATGCTGAAG TTTCATAAATATACC ATCGGCCATGCTTGG ACCACTGATTATGGG 
 A  Q  V  G  V   M  D  M  L  K   F  H  K  Y  T   I  G  H  A  W   T  T  D  Y  G  
TGCTCGGACAGCAAA CAACACTTTGAATGG CTTGTCAAATACTCT CCATTGCATAATGTG AAGTTACCAGAAGCA 
 C  S  D  S  K   Q  H  F  E  W   L  V  K  Y  S   P  L  H  N  V   K  L  P  E  A  
GATGACATCCAGTAC CCGTCCATGCTGCTC CTCACTGCTGACCAT GATGACCGCGTGGTC CCGCTTCACTCCCTG 
 D  D  I  Q  Y   P  S  M  L  L   L  T  A  D  H   D  D  R  V  V   P  L  H  S  L  
AAGTTCATTGCCACC CTTCAGTACATCGTG GGCCGCAGCAGGAAG CAAAGCAACCCCCTG CTTATCCACGTGGAC 
 K  F  I  A  T   L  Q  Y  I  V   G  R  S  R  K   Q  S  N  P  L   L  I  H  V  D  
ACCAAGGCGGGCCAC GGGGCGGGGAAGCCC ACAGCCAAAGTGATA GAGGAAGTCTCAGAC ATGTTTGCGTTCATC 
 T  K  A  G  H   G  A  G  K  P   T  A  K  V  I   E  E  V  S  D   M  F  A  F  I  
GCGCGGTGCCTGAAC GTCGACTGGATTCCA TAA 
 A  R  C  L  N   V  D  W  I  P   * 
Figure 10 (cont’d): BLAST result of hPEP contig sequence yielded a 99.9% identity with Homo sapiens 
prolyl endopeptidase from the NCBI database. Changes in nucleotides were shown in bold. A (see previous 
page) is the contig (query) sequence, whereas B is the subject sequence. The sequences were aligned to 
determine the location of mismatched bases (http://www.fr33.net/translator.php).  
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Transformation of Expression Host with pLIC-hPEP 
 Prior to transforming the pLIC-hPEP into the expression host 
BL21(DE3)+pTF-S E. coli cell line, the host had to be made competent by using 
the CaCl2 Tris buffer method. A glycerol stock of the BL21s was used inoculate 
an overnight culture of LB broth containing 34 µg/mL chloramphenicol. 100 µL of 
the overnight culture was used to inoculate a fresh culture of LB+chlor. The 
optical density at 600nm was measured until it reached approximately 0.6 (Table 
14). After achieving this OD, the cells were carried through the CaCl2 Tris 
protocol and made competent. An aliquot of the competent cells was transformed 
with the pLIC-hPEP construct. For the transformation, two different amounts of 
plasmid DNA were used (2 µL and 5 µL). The cells were plated in duplicate at 
aliquots of 100 µL and 50 µL; the remaining volume was centrifuged, decanted, 
re-suspended, and then plated. The number of colonies that grew after the 
transformation were recorded and are listed in Table 15. Only the transformation 
involving 2 µL of plasmid DNA produced colonies. Increasing plasmid DNA to     
5 µL likely resulted in decreased transformation efficiency. The colonies that 
grew were screened by PCR for hPEP. The PCR products were loaded onto a 
1% agarose gel for confirmation (Figure 11). Out of the three colonies screened, 
only 1 showed a band of ~2133 bp. The colony that was shown to be a 
successful transformant was cloned and subcultured into several glycerol stocks
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Table 14: The optical density at 600nm of BL21(DE3)+pTF-S was measured 
intermittently until the culture reached an approximate OD of 0.6. 
   BL21(DE3)+pTF-S 
Time OD600 
Start 0.01 
60 min 0.0479 
183 min 0.0675 
278 min 0.2664 
317 min 0.568 
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Table 15: The number of colonies/potential transformants that grew following the 
transformation of BL21(DE3)-pTF-S cells with the hPEP construct. The BL21 
cells grew lawns on each control plate, indicating the cells remained viable 
through the transformation protocol. Only cells transformed with 2 µL of construct 
produced colonies. Cells transformed with 5 µL of construct exhibited decreased 
transformation efficiency.  
 
 
  
 
Sample (V:I)→ 
Volume ↓ 
2  µL hPEP 5  µL hPEP 
100 µL 2 No Growth 
100 µL No Growth No Growth 
50 µL 1 No Growth 
50 µL No Growth No Growth 
Resuspended No Growth No Growth 
Control 1 Control 2 Control 3 
 
LAWN LAWN LAWN 
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Figure 11: Confirmation of pLIC-hPEP construct in BL21(DE3)+pTF-S.  
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Expression and Purification of hPEP 
 Several expression studies were performed. The methods for optimized 
expression are as listed in the Material and Methods. Of the studies, two yielded 
sufficient activity for kinetic analysis. For these studies, six liter cultures of the 
BL21(DE3)pTF-S + pLIC-hPEP were grown in 2x LB + Kan + chlor. At an OD600 
of approximately 0.6, IPTG was added to a final concentration of 4 mM, inducing 
enzyme expression. The culture continued to grow overnight and was harvested 
the following day. The lysates collected from this were run over a Ni affinity 
column. The enzyme was eluted using an increasing gradient of imidazole. 
Fractions were collected in 5 mL increments and screened for activity using 
GPpNA assays. Fractions that demonstrated activity were pooled and 
concentrated using Centricep® Centrifugal filter devices with a Ultracel® 50K 
membrane. 
Determination of Km and Vmax of hPEP 
 GPpNA assays were conducted using concentrated hPEP isolated from 
two different expression experiments. The substrate concentration was varied, 
allowing for the determination of Km and Vmax by taking the slopes of the linear 
portions of graphs. First, the amount of pNA in µMol released was plotted versus 
time (Figure 12). The slopes were determined by linear regression. The 
magnitude of the slope is the velocity (Vₒ) at which pNA is released in µMol/min. 
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Plotting Vₒ Vs substrate concentration ([S]) produces the Michaelis-Menton plot 
(Figure 13, A) whereas taking the inverse of the points (1/Vₒ and 1/[S]) yields the 
Line-weever-Burk plot (Figure 13, B). Using linear regression analysis, the Km 
and Vmax of hPEP was determined to be 9.9 µM ± 0.7 and 4.0 µmol/min ± 1 
respectively. 
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Figure 12: Varied substrate for determining the Km of hPEP. GPpNA 
assays were conducted using hPEP isolated from two different expression 
experiments (A) and (B). The assays were run at 410 nm and the absorbance 
was measured every 9 seconds for 1 hour. The substrate concentration was 
varied, allowing for the determination of Km and Vmax by taking the slopes of 
the linear portions of the graphs.   
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Figure 13: Michaelis-Menton and Lineweever Burk plots from GPpNA 
assays of hPEP. GPpNA assays were performed using two different batches of 
enzyme, containing 48 U and 30 U. The slopes of each line from Conc. Vs Time 
(A) and (B) were determined by linear regression. The magnitude of the slope is 
the velocity (Vₒ) at which pNA is released in µMol/min. Plotting Vₒ Vs substrate 
concentration ([S]) produces the Michaelis-Menton plot, whereas taking the 
inverse of the points (1/Vₒ and 1/[S]) gives the Line-weever-Burk plot. Using 
linear regression analysis, the Km’s were estimated by determining 1/x-intercept. 
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Determination of Total Protein in hPEP Samples for SDS-PAGE 
 To determine the total protein content within the cell lysates, a Bradford 
assay was performed. This was done by comparing the absorbance values of the 
lysates to that of BSA on linear portion of the curve and extrapolating the 
concentration. Known concentrations of BSA from 0.6 µg/mL to 10.0 µg/mL were 
used to plot the standard curve (Figure 14, A). The linear portion of the curve 
comprised 0.6 µg/mL to 2.0µg/mL BSA, shown in Figure 14, B.  The total protein 
content of the concentrated hPEP samples from the two expression studies was 
measured to be 120 µg/µL and 70 µg/µL, respectively. A sample from two 
different concentrated flow-through volumes (produced while washing the nickel 
bound enzyme resin) were measured for total protein content, which was 
determined to be 22 µg/µL and 30 µg/µL, respectively. 
For SDS-PAGE visualization, 20 µg of  each sample was loaded. Lanes 1 
and 3 were loaded with the flow-through from the two expression studies, while 
lanes 2 and 4 were loaded with the concentrated hPEP fractions. Lane 5 was 
loaded with a concentrated and purified sample of spPEP for reference. The 
resulting gel (Figure 15) demonstrated a band consistent with the expected 70 
kD for hPEP in each of the sample lanes. The lane loaded with spPEP also 
showed a band at approximately 70 kD. In each lane containing hPEP, there is a 
high presence of contaminating proteins, indicating low purification. 
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Figure 14: Bradford assay standard curve for the absorbance of BSA. The 
Bradford assay was performed to measure total protein content in the cell 
lysates. This was done by comparing the absorbance values of the lysates to that 
on linear portion of the curve and extrapolating the concentration. Known 
concentrations of BSA from 0.6 µg/mL to 10.0 µg/mL were used to plot the 
standard curve. The linear portion of the curve comprised 0.6 µg/mL to 2.0µg/mL 
BSA. The complete curve is shown in (A). The linear portion shown within the red 
rectangle (L) is shown on larger scale (B).  
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Figure 15: The lysates and concentrated fractions of hPEP were analyzed 
using SDS-PAGE. Lanes 1 and 3 correspond to the concentrated flow-through 
samples. Lanes 2 and 4 represent two different concentrated samples of 
pooled fractions that demonstrated hPEP activity. Potential bands that signify 
hPEP (80 kD) are shown within the white rectangles. Lane 5 contains a purified 
sample of spPEP for reference. M represents Precision Plus Protein™ 
Standards molecular marker (Bio-RAD, Corp.). 
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DISCUSSION 
 The primary focus of this study was to clone and express recombinant 
hPEP in BL21(DE3)+pTF-S cells and perform subsequent kinetic studies on the 
expressed enzyme. The current experiment began with cloning hPEP and the 
pLIC vector into JM109 and then purifying them for ligation independent cloning. 
pLIC was digested using SnaBI and thereafter, the vector and hPEP were treated 
with T4 DNA polymerase to allow for ligation. The pLIC-hPEP was then 
sequenced and aligned to the sequence published within the NCBI database. 
 Alignment showed 2 base substitutions and 1 amino acid change for the 
recombinant hPEP. These sequence variations may be due to differences in the 
specimen from which they were originally obtained or an error that occurred 
during sequencing or during amplification by polymerase reaction. To confirm 
that any mutation that took place, the sequencing could be replicated using 
multiple clones. If a change did indeed occur, this could be repaired using site 
directed mutagenesis. 
While a change in a single amino acid could be problematic due to 
possibly changing the conformation of the overall enzyme, it is not expected this 
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amino acid variation had much impact on the results. hPEP demonstrated 
hydrolysis of the GPpNA in the assay, indicating that the catalytic triad within the 
enzyme remained intact. 
Troubleshooting- 
Expression studies of hPEP yielded significant amounts of active enzyme. 
The purification of hPEP was attempted several times by using a Ni-NTA column 
with standard protocol for immobilized metal affinity chromatography (IMAC), but 
the enzyme continued to come off the nickel during the early washes, as well as 
throughout the imidazole gradient. Modifications to the column purification were 
made, including adjusting pH, adding urea prior to the wash, and changing the 
nickel resin. The addition of urea increased the amount of enzyme that came off 
during the wash before adding imidazole. When reviewing the sequencing data, 
the 10x his-tag was found to be present on the N-terminus of the enzyme. With 
this his-tag, the enzyme was expected to stick to the nickel resin well enough to 
purify by IMAC, but it continued to come off in the wash during every attempt. It is 
possible that the his-tag was shielded by a hydrophobic region of the enzyme 
and therefore only bound weakly to the nickel if at all. 
The SDS-PAGE gels had multiple bands throughout, including a few that 
are consistent with the theoretical molecular weight of hPEP (Figure 15). The 
gels were inconclusive due to the large presence of contaminating proteins that 
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came off the column with the hPEP. To correct for this, the enzyme in study must 
first be purified and then analyzed by SDS-PAGE. 
Future Studies- 
 To solve the problem of hPEP not sticking to the nickel resin, a new 
recombinant hPEP will be designed to have a 10x his-tag on the C-terminus. 
Following similar steps as detailed in this study, the recombinant hPEP will be 
cloned into the expression host. Future expression studies using the recombinant 
hPEP will be performed, which is expected to then be able to be purified using 
Ni-NTA IMAC. The purified enzyme will be used for inhibition studies for side-by-
side comparison of hPEP to spPEP. 
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APPENDIX A 
 
Alignment of Contig to hPEP cDNA 
Contig 
 
hPEP 
ATGCTGTCCCTTCAGTACCCCGACGTGTACCGCGACGAGACCGCCGTACAGGATTATCAT 
 
ATGCTGTCCCTTCAGTACCCCGACGTGTACCGCGACGAGACCGCCGTACAGGATTATCAT 
*********************************************************** 
60 
 
60 
 
Contig 
 
hPEP 
GGTCATAAAATTTGTGACCCTTACGCCTGGCTTGAAGACCCCGACAGTGAACAGACTAAG 
 
GGTCATAAAATTTGTGACCCTTACGCCTGGCTTGAAGACCCCGACAGTGAACAGACTAAG                
*********************************************************** 
120 
 
120 
Contig 
 
hPEP 
GCCTTTGTGGAGGCCCAGAATAAGATTACTGTGCCATTTCTTGAGCAGTGTCCCATCAGA 
 
GCCTTTGTGGAGGCCCAGAATAAGATTACTGTGCCATTTCTTGAGCAGTGTCCCATCAGA 
*********************************************************** 
180 
 
180 
Contig 
 
hPEP 
GGTTTATACAAAGAGAGAATGACTGAACTATATGATTATCCCAAGTATAGTTGCCACTTC 
 
GGTTTATACAAAGAGAGAATGACTGAACTATATGATTATCCCAAGTATAGTTGCCACTTC                
********************************************************** 
240 
 
240 
 
Contig 
 
hPEP 
AAGAAAGGAAAACGGTATTTTTATTTTTACAATACAGGTTTGCAGAACCAGCGAGTATTA 
 
AAGAAAGGAAAACGGTATTTTTATTTTTACAATACAGGTTTGCAGAACCAGCGAGTATTA                
********************************************************** 
300 
 
300 
 
Contig 
 
hPEP 
TATGTACAGGATTCCTTAGAGGGTGAGGCCAGAGTGTTCCTGGACCCCAACATACTGTCT 
 
TATGTACAGGATTCCTTAGAGGGTGAGGCCAGAGTGTTCCTGGACCCCAACATACTGTCT 
*********************************************************** 
360 
 
360 
 
Contig 
 
hPEP 
GACGATGGCACAGTGGCACTCCGAGGTTATGCGTTCAGCGAAGATGGTGAATATTTTGCC 
 
GACGATGGCACAGTGGCACTCCGAGGTTATGCGTTCAGCGAAGATGGTGAATATTTTGCC 
*********************************************************** 
420 
 
420 
 
Contig 
 
hPEP 
TATGGTCTGAGTGCCAGTGGCTCAGACTGGGTGACAATCAAGTTCATGAAAGTTGATGGT 
 
TATGGTCTGAGTGCCAGTGGCTCAGACTGGGTGACAATCAAGTTCATGAAAGTTGATGGT 
*********************************************************** 
480 
 
480 
 
Contig 
 
hPEP 
GCCAAAGAGCTTCCAGATGTGCTTGAAAGAGTCAAGTTCAGCTGTATGGCCTGGACCCAT 
 
GCCAAAGAGCTTCCAGATGTGCTTGAAAGAGTCAAGTTCAGCTGTATGGCCTGGACCCAT 
*********************************************************** 
540 
 
540 
 
Contig 
 
hPEP 
GATGGGAAGGGAATGTTCTACAACTCATACCCTCAACAGGATGGAAAAAGTGATGGCACA 
 
GATGGGAAGGGAATGTTCTACAACTCATACCCTCAACAGGATGGAAAAAGTGATGGCACA 
*********************************************************** 
600 
 
600 
 
Contig 
 
hPEP 
GAGACATCTACCAATCTCCACCAAAAGCTCTACTACCATGTCTTGGGAACCGATCAGTCA 
 
GAGACATCTACCAATCTCCACCAAAAGCTCTACTACCATGTCTTGGGAACCGATCAGTCA 
*********************************************************** 
660 
 
660 
 
Contig 
 
hPEP 
GAAGATATTTTGTGTGCTGAGTTTCCTGATGAACCTAAATGGATGGGTGGAGCTGAGTTA 
 
GAAGATATTTTGTGTGCTGAGTTTCCTGATGAACCTAAATGGATGGGTGGAGCTGAGTTA 
*********************************************************** 
720 
 
720 
 
73 
 
Contig 
 
hPEP 
TCTGATGATGGCCGCTATGTCTTGTTATCAATAAGGGAAGGATGTGATCCAGTAAACCGA 
 
TCTGATGATGGCCGCTATGTCTTGTTATCAATAAGGGAAGGATGTGATCCAGTAAACCGA 
*********************************************************** 
780 
 
780 
 
Contig 
 
hPEP 
CTCTGGTACTGTGACCTACAGCAGGAATCCAGTGGCATCGCGGGAATCCTGAAGTGGGTA 
 
CTCTGGTACTGTGACCTACAGCAGGAATCCAGTGGCATCGCGGGAATCCTGAAGTGGGTA 
************************************************************ 
840 
 
840 
 
Contig 
 
hPEP 
AAACTGATTGACAACTTTGAAGGGGAATATGACTACGTGACCAATGAGGGGACGGTGTTC 
 
AAACTGATTGACAACTTTGAAGGGGAATATGACTACGTGACCAATGAGGGGACGGTGTTC 
*********************************************************** 
900 
 
900 
 
Contig 
 
hPEP 
ACATTCAAGACGAATCGCCAGTCTCCCAACTATCGCGTGATCAACATTGACTTCAGGGAT 
 
ACATTCAAGACGAATCGCCAGTCTCCCAACTATCGCGTGATCAACATTGACTTCAGGGAT 
*********************************************************** 
960 
 
960 
 
Contig 
 
hPEP 
CCTGAAGAGTCTAAGTGGAAAGTACTTGTTCCTGAGCATGAGAAAGATGTCTTAGAATGG 
 
CCTGAAGAGTCTAAGTGGAAAGTACTTGTTCCTGAGCATGAGAAAGATGTCTTAGAATGG 
*********************************************************** 
1020 
 
1020 
 
Contig 
 
hPEP 
ATAGCTTGTGTCAGGTCCAACTTCTTGGTCTTATGCTACCTCCATGACGTCAAGAACATT 
 
ATAGCTTGTGTCAGGTCCAACTTCTTGGTCTTATGCTACCTCCATGACGTCAAGAACATT 
********************************************************** 
1080 
 
1080 
 
Contig 
 
hPEP 
CTGCAGCTCCATGACCTGACTACTGGTGCTCTCCTTAAGACCTTCCCGCTCGATGTCGGC 
 
CTGCAGCTCCATGACCTGACTACTGGTGCTCTCCTTAAGACCTTCCCGCTCGATGTCGGC 
*********************************************************** 
1140 
 
1140 
 
Contig 
 
hPEP 
AGCATTGTAGGGTACAGCGGTCAGAAGAAGGACACTGAAATCTTCTATCAGTTTACTTCC 
 
AGCATTGTAGGGTACAGCGGTCAGAAGAAGGACACTGAAATCTTCTATCAGTTTACTTCC 
*********************************************************** 
1200 
 
1200 
 
Contig 
 
hPEP 
TTTTTATCTCCAGGTATCATTTATCACTGTGATCTTACCAAAGAGGAGCTGGAGCCAAGA 
 
TTTTTATCTCCAGGTATCATTTATCACTGTGATCTTACCAAAGAGGAGCTGGAGCCAAGA 
********************************************************** 
1260 
 
1260 
 
Contig 
 
hPEP 
GTTTTCCGAGAGGTGACCGTAAAAGGAATTGATGCTTCTGATTACCAGACAGTCCAGATT 
 
GTTTTCCGAGAGGTGACCGTAAAAGGAATTGATGCTTCTGATTACCAGACAGTCCAGATT             
********************************************************** 
1320 
 
1320 
 
Contig 
 
hPEP 
AAATTGGATGGCTCTCATCCAGCTTTCTTATATGGCTATGGCGGCTTCAACATATCCATC 
 
AAATTGGATGGCTCTCATCCAGCTTTCTTATATGGCTATGGCGGCTTCAACATATCCATC                
********************************************************** 
1440 
 
1440 
 
Contig 
 
hPEP 
ACACCCAACTACAGTGTTTCCAGGCTTATTTTTGTGAGACACATGGGTGGTATCCTGGCA 
 
ACACCCAACTACAGTGTTTCCAGGCTTATTTTTGTGAGACACATGGGTGGTATCCTGGCA                
*********************************************************** 
1500 
 
1500 
 
Contig 
 
hPEP 
GTGGCCAACATCAGAGGAGGTGGCGAATATGGAGAGACGTGGCATAAAGGTGGTATCTTG 
 
GTGGCCAACATCAGAGGAGGTGGCGAATATGGAGAGACGTGGCATAAAGGTGGTATCTTG           
************************************************************ 
1560 
 
1560 
 
74 
 
Contig 
 
hPEP 
GCCAACAAACAAAACCGCTTTGATGACTTTCAGTGTGCTGCTGAGTATCTGATCAAGGAA 
 
GCCAACAAACAAAACTGCTTTGATGACTTTCAGTGTGCTGCTGAGTATCTGATCAAGGAA 
**************_******************************************* 
1620 
 
1620 
 
Contig 
 
hPEP 
GGTTACACATCTCCCAAGAGGCTGACTATTAATGGAGGTTCAAATGGAGGCCTCTTAGTG 
 
GGTTACACATCTCCCAAGAGGCTGACTATTAATGGAGGTTCAAATGGAGGCCTCTTAGTG                
*********************************************************** 
1680 
 
1680 
 
Contig 
 
hPEP 
GCTGCTTGTGCAAATCAGAGACCTGACCTCTTTGGTTGTGTTATTGCCCAAGTTGGAGTA 
 
GCTGCTTGTGCAAATCAGAGACCTGACCTCTTTGGTTGTGTTATTGCCCAAGTTGGAGTA                
********************************************************** 
1740 
 
1740 
 
Contig 
 
hPEP 
ATGGACATGCTGAAGTTTCATAAATATACCATCGGCCATGCTTGGACCACTGATTATGGG 
 
ATGGACATGCTGAAGTTTCATAAATATACCATCGGCCATGCTTGGACCACTGATTATGGG                
*********************************************************** 
1800 
 
1800 
 
Contig 
 
hPEP 
TGCTCGGACAGCAAACAACACTTTGAATGGCTTGTCAAATACTCTCCATTGCATAATGTG 
 
TGCTCGGACAGCAAACAACACTTTGAATGGCTTGTCAAATACTCTCCATTGCATAATGTG                
********************************************************** 
1860 
 
1860 
 
Contig 
 
hPEP 
AAGTTACCAGAAGCAGATGACATCCAGTACCCGTCCATGCTGCTCCTCACTGCTGACCAT 
 
AAGTTACCAGAAGCAGATGACATCCAGTACCCGTCCATGCTGCTCCTCACTGCTGACCAT                
*********************************************************** 
1920 
 
1920 
 
Contig 
 
hPEP 
GATGACCGCGTGGTCCCGCTTCACTCCCTGAAGTTCATTGCCACCCTTCAGTACATCGTG 
 
GATGACCGCGTGGTCCCGCTTCACTCCCTGAAGTTCATTGCCACCCTTCAGTACATCGTG 
*********************************************************** 
1980 
 
1980 
 
Contig 
 
hPEP 
GGCCGCAGCAGGAAGCAAAGCAACCCCCTGCTTATCCACGTGGACACCAAGGCGGGCCAC 
 
GGCCGCAGCAGGAAGCAAAGCAACCCCCTGCTTATCCACGTGGACACCAAGGCGGGCCAC                
************************************************************* 
2040 
 
2040 
 
Contig 
 
hPEP 
GGGGCGGGGAAGCCCACAGCCAAAGTGATAGAGGAAGTCTCAGACATGTTTGCATTCATC 
 
GGGGCGGGGAAGCCCACAGCCAAAGTGATAGAGGAAGTCTCAGACATGTTTGCGTTCATC                
*****************************************************_****** 
2100 
 
2100 
 
Contig 
 
hPEP 
GCGCGGTGCCTGAACGTCGACTGGATTCCATAA 
 
GCGCGGTGCCTGAACGTCGACTGGATTCCATAA 
********************************* 
2134 
 
2134 
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